polmacoxib

Ligand id: 8316

Name: polmacoxib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 94.84
Molecular weight 361.08
XLogP 3.45
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Polmacoxib was approved in South Korea in early 2015, for the treatment of osteoarthritis, following positive outcomes from a Phase III clinical trial (NCT01765296).